Efficacy and safety of the cyclooxygenase 2 inhibitors parecoxib and valdecoxib in patients undergoing coronary artery bypass surgery. J. Thorac. - Ott,E..; Nussmeier,N.; Duke,P.; Feneck,R.; Alston,R.; Snabes,M.; Hubbard,R.; Hsu,P.; Saidman,L.; Mangano,D.. (Cardiovasc. Surg, 2003)